Anti-LRP1 antibody [EPR3724],Abcam,AB92544

Anti-LRP1 antibody [EPR3724] (ab92544) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP, WB in human, mouse, pig, rat samples. Anti-LRP1 antibody [EPR3724] (ab92544) has been cited over 194 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-LRP1 antibody [EPR3724] (ab92544) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-LRP1 antibody [EPR3724] (ab92544) has been confirmed by testing in knockout samples. Anti-LRP1 antibody [EPR3724] (ab92544) has 9 independent reviews from customers. Anti-LRP1 antibody [EPR3724] (ab92544) specifically detects LRP1 (UniProt ID: Q07954; Molecular weight: 503kDa) and is sold in a convenient trial size to enable initial testing (20 uL) and larger sizes for subsequent scaling up experiments (100 uL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR3724 - ab215997 . Antibody clone EPR3724 is also available pre-conjugated to a variety of labels for your convenience - HRP, APC, PE, Alexa Fluor® 568, Alexa Fluor® 555 ( ab195569 , ab31885 , ab31941, ab312965 , ab313174 ). Low-density lipoprotein receptor-related protein (LRP) is a versatile receptor that plays a crucial role in various physiological functions, including lipid metabolism, endocytosis, and cellular signaling. It is particularly important in the clearance of amyloid-beta peptides, which are linked to Alzheimer's disease (AD). Changes in LRP expression or function are associated with a range of diseases, such as cardiovascular diseases, neurodegenerative disorders like AD, and certain types of cancer. Studying LRP provides valuable insights into its role in these conditions and the underlying mechanisms, underscoring its significance in disease pathology research. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .